Close

Analyst Ratings for Karyopharm Therapeutics (KPTI)

KPTI Rating Summary

KPTI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KPTI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $5.67 (+260.9%) * Over Last 12-Mos
Rating Score: 7.1 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/19/2023 Piper Sandler
» Updated 11/2/2023
Christopher Reynolds New Coverage Overweight
(N/A)
5.00
(7.00)
3.11
(1.57)
-49.52% Details
11/4/2022 RBC Capital
» Updated 11/3/2023
Brian Abrahams Upgrade Outperform
(Sector Perform)
3.00
(4.00)
4.54
(1.57)
-65.42% Details
Like KPTI Ratings? Also take a look at BMY

KPTI Ratings News